Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. STKE, 10 April 2007
Vol. 2007, Issue 381, p. pe13
[DOI: 10.1126/stke.3812007pe13]

MEETING REPORTS

Meeting Report: Tumor Biology--How Signaling Processes Translate to Therapy

Karlheinz Friedrich1, Ottmar Janssen2, and Ralf Hass3*

1Institute of Biochemistry, Friedrich-Schiller University, 07743 Jena, Germany.
2Institute of Immunology, Christian-Albrechts University, 24105 Kiel, Germany.
3Biochemistry and Tumor Biology, Medical School, 30625 Hannover, Germany.

A report on the "Signal Transduction Society (STS) Meeting 2006: Signal Transduction-Receptors, Mediators and Genes," Weimar, Germany, 2 to 4 November 2006.

Abstract: On the occasion of the 10th Joint Meeting "Signal Transduction—Receptors, Mediators and Genes" in November 2006, the Signal Transduction Society (STS) focused on the holy grail of translational research, that is, how basic signaling research might be transferred into cancer therapy. Participants heard of blockbusters and setbacks and learned of new therapeutic approaches that concentrate on distinct signaling pathways at a more individual level. Thus, the young STS community and the 300 meeting participants left with an optimistic outlook and the notion that the translational task will keep scientists busy all over the world for a while.

*Corresponding author: E-mail, hass.ralf{at}mh-hannover.de

Citation: K. Friedrich, O. Janssen, R. Hass, Meeting Report: Tumor Biology--How Signaling Processes Translate to Therapy. Sci. STKE 2007, pe13 (2007).

Read the Full Text


To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882